Clinical and molecular genetic analysis of best vitelliform macular dystrophy

Retina

Volumn 29, Issue 6, 2009, Pages 835-847

  Boon, Camiel J F ^a   Theelen, Thomas ^a   Hoefsloot, Elisabeth H ^a   Van Schooneveld, Mary J ^b   Keunen, Jan E E ^a   Cremers, Frans P M ^a,c   Klevering, B Jeroen ^a   Hoyng, Carel B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTOFLUORESCENCE; BEST1 GENE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL GENETICS; ELECTROOCULOGRAPHY; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENE; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; MALE; MOLECULAR GENETICS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; RETINA MACULA VITELLIFORM DEGENERATION; RETROSPECTIVE STUDY; SCHOOL CHILD; VISUAL ACUITY;

ADOLESCENT; ADULT; CHILD; CHLORIDE CHANNELS; ELECTROOCULOGRAPHY; EYE PROTEINS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; MUTATION; OPHTHALMOSCOPY; PHENOTYPE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 67749091133     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31819d4fda     Document Type: Article

References (44)

1. Gass JD. Heredodystrophic disorders affecting the pigment epithelium and retina. 4th ed. In: Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Vol. 1. St. Louis: C.V. Mosby; 1997:304-311.
2. Wabbels B, Preising MN, Kretschmann U, Demmler A, Lorenz B. Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol 2006;244:1455-1466.
3. Weber BH, Walker D, Muller B. Molecular evidence for non-penetrance in Best's disease. J Med Genet 1994;31:388- 392.
4. Kramer F, White K, Pauleikhoff D, et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet 2000;8:286-292.
5. Marmorstein AD, Kinnick TR. Focus on molecules: bestrophin (Best-1). Exp Eye Res 2006;85:423-424.
6. Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet 1998; 19:241-247.
7. Hartzell HC, Qu Z, Yu K, Xiao Q, Chien LT. Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. Physiol Rev 2008;88:639-672.
8. Burgess R, Millar ID, Leroy BP, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet 2008;82:19-31.
9. Yardley J, Leroy BP, Hart-Holden N, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci 2004;45:3683-3689.
10. Glybina IV, Frank RN. Localization of multifocal electroretinogram abnormalities to the lesion site: findings in a family with Best disease. Arch Ophthalmol 2006;124:1593-1600.
11. Palmowski AM, Allgayer R, Heinemann-Vernaleken B, Scherer V, Ruprecht KW. Detection of retinal dysfunction in vitelliform macular dystrophy using the multifocal ERG (MF-ERG). Doc Ophthalmol 2003;106:145-152.
12. Scholl HP, Schuster AM, Vonthein R, Zrenner E. Mapping of retinal function in Best macular dystrophy using multifocal electroretinography. Vision Res 2002;42:1053-1061.
13. Renner AB, Tillack H, Kraus H, et al. Late onset is common in best macular dystrophy associated with VMD2 gene mutations. Ophthalmology 2005;112:586-592.
14. Boon CJF, Klevering BJ, den Hollander AI, et al. Clinical and genetic heterogeneity in multifocal vitelliform dystrophy. Arch Ophthalmol 2007;125:1100-1106.
15. Mohler CW, Fine SL. Long-term evaluation of patients with Best's vitelliform dystrophy. Ophthalmology 1981;88:688- 692.
16. Costa RA, Skaf M, Melo LA Jr, et al. Retinal assessment using optical coherence tomography. Prog Retin Eye Res 2006;25: 325-353.
17. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995;36:718-729.
18. von Ruckmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 1997;115:609-615.
19. Frangieh GT, Green WR, Fine SL. A histopathologic study of Best's macular dystrophy. Arch Ophthalmol 1982;100:1115- 1121.
20. O'Gorman S, Flaherty WA, Fishman GA, Berson EL. Histopathologic findings in Best's vitelliform macular dystrophy. Arch Ophthalmol 1988;106:1261-1268.
21. Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best's macular dystrophy. Arch Ophthalmol 1982;100:1108- 1114.
22. Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001;42:1051-1056.
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
24. Marquardt A, Stohr H, Passmore LA, Kramer F, Rivera A, Weber BH. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). Hum Mol Genet 1998;7: 1517-1525.
25. Bakall B, Marknell T, Ingvast S, et al. The mutation spectrum of the bestrophin protein-functional implications. Hum Genet 1999;104:383-389.
26. Lotery AJ, Munier FL, Fishman GA, et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci 2000;41:1291-1296.
27. Mullins RF, Oh KT, Heffron E, Hageman GS, Stone EM. Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. Arch Ophthalmol 2005;123:1588-1594.
28. Kramer F, Mohr N, Kellner U, Rudolph G, Weber BH. Ten novel mutations in VMD2 associated with Best macular dystrophy (BMD). Hum Mutat 2003;22:418.
29. Clemett R. Vitelliform dystrophy: long-term observations on New Zealand pedigrees. Aust N Z J Ophthalmol 1991;19:221- 227.
30. Spaide R. Autofluorescence from the outer retina and subretinal space: hypothesis and review. Retina 2008;28:5-35.
31. Chung MM, Oh KT, Streb LM, Kimura AE, Stone EM. Visual outcome following subretinal hemorrhage in Best disease. Retina 2001;21:575-580.
32. Bakall B, Radu RA, Stanton JB, et al. Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Exp Eye Res 2007;85:34-43.
33. Mullins RF, Kuehn MH, Faidley EA, Syed NA, Stone EM. Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease. Invest Ophthalmol Vis Sci 2007;48:3372-3380.
34. Andrade RE, Farah ME, Costa RA. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease. Am J Ophthalmol 2003;136:1179-1181.
35. Leu J, Schrage NF, Degenring RF. Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol 2007;245:1723-1725.
36. Yu K, Cui Y, Hartzell HC. The bestrophin mutation A243V, linked to adult-onset vitelliform macular dystrophy, impairs its chloride channel function. Invest Ophthalmol Vis Sci 2006; 47:4956-4961.
37. Hori K, Ishida S, Inoue M, et al. Treatment of cystoid macular edema with oral acetazolamide in a patient with Best vitelli-form macular dystrophy. Retina 2004;24:481-482.
38. Spaide RF, Noble K, Morgan A, Freund KB. Vitelliform macular dystrophy. Ophthalmology 2006;113:1392-1400.
39. Querques G, Regenbogen M, Quijano C, Delphin N, Soubrane G, Souied EH. High-definition optical coherence tomography features in vitelliform macular dystrophy. Am J Ophthalmol 2008;146:501-507.
40. Maruko I, Iida T, Spaide RF, Kishi S. Indocyanine green angiography abnormality of the periphery in vitelliform macular dystrophy. Am J Ophthalmol 2006;141:976-978.
41. Miller SA. Multifocal Best's vitelliform dystrophy. Arch Ophthalmol 1977;95:984-990.
42. Boon CJF, den Hollander AI, Hoyng CB, Cremers FPM, Klevering BJ, Keunen JEE. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog Retin Eye Res 2008;27:213-235.
43. Renner AB, Tillack H, Kraus H, et al. Morphology and functional characteristics in adult vitelliform macular dystrophy. Retina 2004;24:929-939.
44. Zhuk SA, Edwards AO. Peripherin/RDS and VMD2 mutations in macular dystrophies with adult-onset vitelliform lesion. Mol Vis 2006;12:811-815.